AccessOne CEO Mark Spinner spoke to Chief Executive about the shift in healthcare to consumer-facing costs and the challenges this kind environment brings.
The Justice Department approved the $69 billion CVS-Aetna merger. What will be the larger impact of vertical integration in healthcare?
John Carreyrou was one of the few people that saw through Elizabeth Holmes and Theranos when the world was fawning over the Silicon Valley-based health tech company and its enigmatic CEO. The bestselling author of the Theranos expose talks with us about a wide range of topics.
Manufacturing CEOs are feeling quite a bit better about President Trump’s trade-negotiating tactics in the wake of the new U.S.-Mexico-Canada Agreement. In particular, the U.S. auto industry should be happy.
Arguments that regulating high-tech will crater the companies aren’t as compelling as the tech titans will have us believe.
Strong customer demand, lending rates, lower taxes and high employment are some of the variables CEOs say keep their confidence high. Still, tariffs and trade uncertainties remain a concern.
Anthony Tabasso, CEO of KVK Tech, talks with Chief Executive about the challenges in manufacturing a controlled substance, a highly-regulated industry, and manufacturing generic medications with lower price pressure.
America’s trade dispute with China is a morass that threatens to become a tar pit for CEOs of many U.S. manufacturers, even as President Trump’s tariffs provide direct protection of many other companies. Steve Harriott, CEO of Watchfire Signs in Danville, Illinois, is one of the worried ones.
While it is critical for CEOs to understand how the organization’s footprint is aligned to deliver on enterprise objectives, using business climate alone is not sufficient to develop a nuanced footprint strategy.
With new tariffs and tax reforms today’s business landscape presents a myriad of challenges, but it also provides a wealth of opportunities for strategic growth.